BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3138907)

  • 1. Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content.
    Vargas JH; Klein GL; Ament ME; Ott SM; Sherrard DJ; Horst RL; Berquist WE; Alfrey AC; Slatopolsky E; Coburn JW
    Am J Clin Nutr; 1988 Oct; 48(4):1070-8. PubMed ID: 3138907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic bone disease associated with total parenteral nutrition.
    Klein GL; Coburn JW
    Adv Nutr Res; 1984; 6():67-92. PubMed ID: 6439013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum loading during total parenteral nutrition.
    Klein GL; Alfrey AC; Miller NL; Sherrard DJ; Hazlet TK; Ament ME; Coburn JW
    Am J Clin Nutr; 1982 Jun; 35(6):1425-9. PubMed ID: 6805302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum as a factor in the bone disease of long-term parenteral nutrition.
    Klein GL; Ott SM; Alfrey AC; Sherrard DJ; Hazlet TK; Miller NL; Maloney NA; Berquist WE; Ament ME; Coburn JW
    Trans Assoc Am Physicians; 1982; 95():155-64. PubMed ID: 6820740
    [No Abstract]   [Full Text] [Related]  

  • 5. Aluminum does not accumulate in teenagers and adults on prolonged parenteral nutrition containing free amino acids.
    Heyman MB; Klein GL; Wong A; Recker RR; Tyrrell JB; Alfrey AC; Sherrard DJ; Hohn DC
    JPEN J Parenter Enteral Nutr; 1986; 10(1):86-7. PubMed ID: 3080630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition.
    Ott SM; Maloney NA; Klein GL; Alfrey AC; Ament ME; Coburn JW; Sherrard DJ
    Ann Intern Med; 1983 Jun; 98(6):910-4. PubMed ID: 6407375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifactorial low remodeling bone disease during cyclic total parenteral nutrition.
    de Vernejoul MC; Messing B; Modrowski D; Bielakoff J; Buisine A; Miravet L
    J Clin Endocrinol Metab; 1985 Jan; 60(1):109-13. PubMed ID: 3917265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocalcemia complicating deferoxamine therapy in an infant with parenteral nutrition-associated aluminum overload: evidence for a role of aluminum in the bone disease of infants.
    Klein GL; Snodgrass WR; Griffin MP; Miller NL; Alfrey AC
    J Pediatr Gastroenterol Nutr; 1989 Oct; 9(3):400-3. PubMed ID: 2515268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect.
    Shike M; Shils ME; Heller A; Alcock N; Vigorita V; Brockman R; Holick MF; Lane J; Flombaum C
    Am J Clin Nutr; 1986 Jul; 44(1):89-98. PubMed ID: 3088971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible role of vitamin D in the genesis of parenteral-nutrition-induced metabolic bone disease.
    Shike M; Sturtridge WC; Tam CS; Harrison JE; Jones G; Murray TM; Husdan H; Whitwell J; Wilson DR; Jeejeebhoy KN
    Ann Intern Med; 1981 Nov; 95(5):560-8. PubMed ID: 6794407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic bone disease in home total parenteral nutrition.
    McCullough ML; Hsu N
    J Am Diet Assoc; 1987 Jul; 87(7):915-20. PubMed ID: 3110249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone disease associated with total parenteral nutrition.
    Klein GL; Targoff CM; Ament ME; Sherrard DJ; Bluestone R; Young JH; Norman AW; Coburn JW
    Lancet; 1980 Nov; 2(8203):1041-4. PubMed ID: 6107676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum and renal osteodystrophy.
    Nebeker HG; Coburn JW
    Annu Rev Med; 1986; 37():79-95. PubMed ID: 3085581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total parenteral nutrition and its effects on bone metabolism.
    Klein GL; Coburn JW
    Crit Rev Clin Lab Sci; 1994; 31(2):135-67. PubMed ID: 7917007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of 1,25-dihydroxyvitamin D in children receiving parenteral nutrition with reduced aluminum content.
    Klein GL; Horst RL; Alfrey AC; Slatopolsky E
    J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):93-6. PubMed ID: 3920379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic bone disease in patients receiving long-term total parenteral nutrition.
    Shike M; Harrison JE; Sturtridge WC; Tam CS; Bobechko PE; Jones G; Murray TM; Jeejeebhoy KN
    Ann Intern Med; 1980 Mar; 92(3):343-50. PubMed ID: 6766694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic bone diseases during long-term total parenteral nutrition.
    Acca M; Ragno A; Francucci CM; D'Erasmo E
    J Endocrinol Invest; 2007; 30(6 Suppl):54-9. PubMed ID: 17721075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of total parenteral nutrition using Vamin and Aminosyn as protein base in critically ill preterm infants.
    Sankaran K; Berscheid B; Verma V; Zakhary G; Tan L
    JPEN J Parenter Enteral Nutr; 1985; 9(4):439-42. PubMed ID: 3928917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperammonemia during total parenteral nutrition in children.
    Seashore JH; Seashore MR; Riely C
    JPEN J Parenter Enteral Nutr; 1982; 6(2):114-8. PubMed ID: 6808170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of synthetic amino acid and casein hydrolysate on the endogenous production and urinary excretion of acid in total intravenous alimentation.
    Chan JC
    Pediatr Res; 1972 Oct; 6(10):789-96. PubMed ID: 4630808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.